Grants supporting paper: R01 DK35592 (John A. Phillips)
Pharmacologic Correction of Dominant-Negative GH1 Deficiency Causing Mutations
Version of Record online: 27 JUN 2011
© 2011 Wiley Periodicals, Inc.
Clinical and Translational Science
Volume 4, Issue 3, pages 175–179, June 2011
How to Cite
Poling, J. S., Phillips III, J. A., Cogan, J. D. and Hamid, R. (2011), Pharmacologic Correction of Dominant-Negative GH1 Deficiency Causing Mutations. Clinical and Translational Science, 4: 175–179. doi: 10.1111/j.1752-8062.2011.00290.x
- Issue online: 27 JUN 2011
- Version of Record online: 27 JUN 2011
Figure S1. Effect of 100-nm digoxin exposure over a 48-hour interval on GH1 17.5-kDa and 22-kDa transcript levels and the 17.5-/22-kDa transcript ratios.
Figure S2. Effect of 48-hour exposure of 100-nm digoxin on the 17.5-/22-kDa transcript ratios.
Figure S3. Effect of 48-hour exposure of 5-IT 1 μM on the 17.5-/22-kDa transcript ratios.
|CTS_290_sm_FigureS1.tif||89K||Supporting info item|
|CTS_290_sm_FigureS2.tif||72K||Supporting info item|
|CTS_290_sm_FigureS3.tif||68K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.